Publications by authors named "Quanli Han"

Claim this Profile
E
Efficacy, safety, and exploratory biomarker analysis of envafolimab plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer: a prospective, single-arm, phase II trial.
Xiao Zhao, Jing Zhang, Lupeng Qiu, Quanli Han, Xiang Yan, Xiaoling Zhang, Shunchang Jiao

BMC Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line treatment with chemotherapy, surufatinib (an angio-immuno kinase inhibitor), and camrelizumab (an anti-PD-1 antibody) for locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II randomized study.
Ru Jia, Hai-Yan Si, Meng-Jiao Fan, Nan Zhang, Guo-Chao Deng, Lu Han, Xia Zhang, Yao-Yue Zhang, Yu-Shan Jia, Quan-Li Han

Signal Transduct Target Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIGD6 in gastric cancer: exploring its prognostic value and therapeutic potential through molecular and clinical investigations.
Quanli Han, Muhong Deng, Zhi Cui, Qi Wang, Dongbing Li

Eur J Med Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nimotuzumab plus chemotherapy and immunotherapy as first-line/neoadjuvant therapy for advanced esophageal squamous cell carcinoma.
Qi Wang, Zhi Cui, Muhong Deng, Guoqing Zhang, Fangfang Jing, Quanli Han

Front Pharmacol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of lung immune prognostic index with overall survival in pancreatic ductal adenocarcinoma patients treated using chemotherapy.
Nan Zhang, Guochao Deng, Ru Jia, Quanli Han, Guanghai Dai

Int J Med Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of the Predictive and Prognostic ChemoResist Signature in Resected Pancreatic Ductal Adenocarcinoma: Multicohort Study.
Lei Huang, Quanli Han, Liangchao Zhao, Zhikuan Wang, Guanghai Dai

Ann Surg· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of sintilimab plus bevacizumab and CAPOX as first-line treatment for patients with RAS-mutant, microsatellite stable, metastatic colorectal cancer.
Yanrong Wang, Ru Jia, Haiyan Si, Yue Ma, Mengjiao Fan, Nan Zhang, Yushan Jia, Yaoyue Zhang, Quanli Han

BMC Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition).
Haowen Tang, Wenwen Zhang, Junning Cao, Yinbiao Cao, Xinyu Bi, Ze Zhang, Jushan Wu, Wanguang Zhang, Kaishan Tao, Keming Zhang, Quanli Han, Shunchang Jiao, Zhanbo Wang, Meng Zhang, Jialin Zhang

Biosci Trends· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective study.
Lei Huang, Yao Lv, Shasha Guan, Huan Yan, Lu Han, Quanli Han

J Transl Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications.
Zhiming Zhao, Xiaomo Li, Fei Wang, Yong Xu, Si Liu, Quanli Han

Cancer Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene signature developed for predicting early relapse and survival in early-stage pancreatic cancer.
Lei Huang, Xiaodong Yuan, Liangchao Zhao, Quanli Han, Huan Yan

BJS Open· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term response to sintilimab, bevacizumab and chemotherapy in heavily pretreated microsatellite stable colon cancer.
Zhi Cui, Qi Wang, Muhong Deng, Erhong Meng, Sheng Liu, Quanli Han

Immunotherapy· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of OTX2-AS1 is Associated With Immune Infiltration and Predicts Prognosis of Gastric Cancer.
Quan-Li Han, Zhi Cui, Qi Wang, Fang Pang, Dongbing Li

Technol Cancer Res Treat· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma.
Shasha Guan, Guochao Deng, Jingjie Sun, Quanli Han, Yao Lv

Front Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis.
Zhi Cui, Qi Wang, Mu-Hong Deng, Quan-Li Han

Cancer Biomark· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S-1 Maintenance Therapy After First-Line Treatment With Nab-Paclitaxel Plus S-1 for Advanced Pancreatic Adenocarcinoma: A Real-World Study.
Yan Shi, Quanli Han, Huan Yan, Yao Lv, Jing Yuan

Front Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinoic Acid-Induced 2 (RAI2) Is a Novel Antagonist of Wnt/β-Catenin Signaling Pathway and Potential Biomarker of Chemosensitivity in Colorectal Cancer.
Weitao Zhang, Lu Kong, Hongbin Zhu, Decong Sun, Quanli Han, Weiwei Zhang, Shurong Zhang

Front Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paired box 5 increases the chemosensitivity of esophageal squamous cell cancer cells by promoting p53 signaling activity.
Weiwei Zhang, Wenji Yan, Niansong Qian, Quanli Han, Weitao Zhang

Chin Med J (Engl)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report and Literature Review: Diagnosis, Tailored Genetic Counseling and Cancer Prevention for a Locally Advanced dMMR/MSI-H/TMB-H Lung Cancer Patient With Concurrent Lynch Syndrome Mediated by a Rare Splicing Variant (c.1144+1G>A).
Quanli Han, Si Liu, Zhi Cui, Qi Wang, Tonghui Ma

Front Genet· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
microRNA-425 promoted the proliferation and migration of colorectal cancer cells by targeting KLF3 through the PI3K/AKT pathway.
Yao Lv, Decong Sun, Quanli Han, Huan Yan, Guanghai Dai

Minerva Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preoperative CA19-9 levels predict disease-free survival and overall survival in pancreatic adenocarcinoma patients after resection.
Shasha Guan, Yang Chen, Quanli Han, Guochao Deng, Yanrong Wang

Transl Cancer Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial growth factor receptor-targeted and reactive oxygen species-responsive lung cancer therapy by docetaxel and resveratrol encapsulated lipid-polymer hybrid nanoparticles.
Zizheng Song, Yan Shi, Quanli Han, Guanghai Dai

Biomed Pharmacother· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nab-paclitaxel plus S-1 in advanced pancreatic adenocarcinoma (NPSPAC): a single arm, single center, phase II trial.
Yan Shi, Sui Zhang, Quanli Han, Jie Li, Huan Yan

Oncotarget· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone demethylase PHF8 accelerates the progression of colorectal cancer and can be regulated by miR-488 in vitro.
Yao Lv, Yan Shi, Quanli Han, Guanghai Dai

Mol Med Rep· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leucine-rich alpha-2-glycoprotein-1, relevant with microvessel density, is an independent survival prognostic factor for stage III colorectal cancer patients: a retrospective analysis.
De-Cong Sun, Yan Shi, Ling-Xiong Wang, Yao Lv, Quan-Li Han

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis